{
  "title": "Paper_218",
  "abstract": "pmc eBioMedicine EBioMedicine 2749 ebiom eBioMedicine 2352-3964 Elsevier PMC12492035 PMC12492035.1 12492035 12492035 40992213 10.1016/j.ebiom.2025.105944 S2352-3964(25)00388-3 105944 1 Articles Transposition of insertion sequence element from KPC plasmid enhances intracellular survival of Klebsiella pneumoniae Xie Yingzhou a g Cao Zu b g Shi Yi-Han a g Shen Xiyue a Wang Le-Le a Weng Dong a Zhang Jianfeng c d Wang Yiting e Li Gang gorrillee@hotmail.com e ∗∗ Xu Jin-Fu jfxucn@163.com a f ∗ a b c d e f ∗ jfxucn@163.com ∗∗ gorrillee@hotmail.com g These authors contributed equally to this work. 10 2025 23 9 2025 120 497285 105944 8 2 2025 6 9 2025 8 9 2025 23 09 2025 04 10 2025 04 10 2025 © 2025 The Author(s) 2025 https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Summary Background The convergence of plasmids encoding Klebsiella pneumoniae K. pneumoniae Kpn K. pneumoniae Kpn Methods An Hv-CR- Kpn Kpn Kpn Kpn Findings The acquisition of virulence plasmid resulted in CPS hyperproduction of CR- Kpn Kpn in vitro in vivo Kpn Kpn Interpretation Loss of CPS production enhances the Kpn Kpn, Funding Noncommunicable Chronic Diseases-National Science and Technology Major Project of China 10.13039/501100001809 National Natural Science Foundation of China Key Scientific Innovation Project of Shanghai Municipal Education Commission and Shanghai Sailing Program Keywords Klebsiella pneumoniae Insertion sequence element Virulence plasmid Multidrug resistance plasmid Antimicrobial resistance pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes  Research in context Evidence before this study The hypervirulent carbapenem-resistant Klebsiella pneumoniae Kpn rmpADC rmpA2 Kpn rmpA Kpn Kpn Added value of this study Using conjugative transfer, we engineered an Hv-CR- Kpn Kpn Kpn Kpn14 Implications of all the available evidence KPC plasmids serve not only as reservoir for antibiotic resistance but also for the mobile genetic elements, particularly the IS elements. The transposition of IS element from KPC plasmid provides an auxiliary mechanism by which Kpn Kpn Introduction Klebsiella pneumoniae Kpn 1 , 2 3 4 5 Kpn 6 , 7 Kpn Kpn 8 Kpn Kpn Kpn 9 , 10 The convergence of hypervirulence (Hv) and carbapenem resistance (CR) in Hv-CR- Kpn Kpn 11 Kpn rmpADC rmpA2 12 13 14 15 Kpn Kpn Kpn 9 , 16 Kpn Kpn Kpn Kpn 10 Kpn 17 Kpn Kpn 18 , 19 Kpn Kpn Kpn Kpn 20 Kpn 11 Kpn, 21 , 22 Kpn Here, we interrogated how KPC plasmid influence virulence plasmid-mediated pathogenicity in ST11 Hv-CR- Kpn Kpn Methods Bacterial strains and culture conditions Kpn NC_016845.1 NZ_CP014008.1 wbaP Kpn14 Kpn Determination of mucoviscosity and quantification of CPS production These experiments were performed using a previously described method. 16 Kpn g The production of CPS by different Kpn Kpn g PCR screening and quantitative reverse-transcription PCR The presences of p rmpA p rmpA2 iucA Table S1 Conjugative transfer of pRJF293 into HS11286 Due to the super low conjugative frequency of pRJF293 to HS11286, two rounds of conjugation were needed to obtain the desired transconjugant, HS11286V. The conjugation assay was performed as previously described. 23 Kpn 4 Table S1 Bacterial adhesion assay The assay was performed as per the protocol in our previous publication, with minor modifications. 19 Kpn Bacterial intracellular survival and intramacrophage competition The intracellular survival and proliferation of Kpn 24 Kpn 2 25 For intracellular competition, Kpn Animal experiments All the animal experiments involved in the present study had been approved by the Shanghai Public Health Clinical Centre's Animal Care and Use Committee (Approval No. 2020-A020-01). The 6-7-week female C57BL/6J mice (RRID: IMSR_JAX:000664) were used for all the animal experiments in the present study. All mice were housed in a biosafety level 2, pathogen-free facility in Shanghai Public Health Clinical Centre. A dosage of 10 7 Kpn 8 Genome sequencing and bioinformatics analysis The genomic DNA of Kpn https://www.bv-brc.org/ 26 27 , 28 Prediction of IS elements was performed using ISfinder, and hits with either coverage or identify greater than 99% were reserved for further analysis. 29 30 31 32 33 Kpn Kpn NC_009648 34 35 , 36 37 Kpn https://bigsdb.pasteur.fr 38 Statistical analysis All the data generated from replicate experiments are presented as the means with standard deviations. The statistical differences between two groups were compared by using unpaired t tests and one-way ANOVA was used for the comparison between more than two groups. Differences with a p Role of funder The funders of this study had no role in the conceptualisation, data acquisition, analysis or interpretation of the present study. They were not involved in the preparation of the manuscript or in the decision to publish. Results Virulence plasmids are prevalent but do not necessarily confer hypermucoviscosity in CR- Kpn A total of 195 Kpn Table S2 p rmpA p rmpA2 iucA Kpn 39 p rmpA p rmpA2 Klebsiella Fig. 1 Fig. 1 Low mucoviscosity in a collection of 195 clinical CR- Kpn rmpA p rmpA rmpA2 p rmpA2 Kpn b. Kpn p rmpA p rmpA2 wzi c. Kpn p rmpA p rmpA2 Kpn Kpn p Kpn Kpn p rmpA p rmpA2 To further characterise these strains, wzi 40 Fig. 1 iucA rmpA 41 Mucoviscosity of these strains was further assessed by using the low-speed centrifugation. As controls, the hypermucoviscous strains Kpn Kpn Fig. S1a–c 42 , 43 Fig. 1 Kpn Kpn p rmpA p rmpA2 Fig. 1 Kpn Hyperproduction of CPS dampened the intracellular survival of ST11 CR- Kpn The hypermucoviscosity is strongly associated with the CPS production. 44 Fig. S1d and e Kpn Fig. S1f Bacterial attachment to eukaryotic cells and the intracellular proliferation are critical steps to establish the colonisation and persistent infection. 45 Kpn p p Fig. 2 Fig. 2 Kpn Fig. S2 Fig. 2 Hyperproduction of CPS dampened the intracellular proliferation of Kpn a and b. Kpn c and d. e-h. p We next investigated the intramacrophage competition between HS11286 and HS11286V with input ratios ranging from 0.2 to 1.7 (HS11286V:HS11286). Although the total bacterial output increased in all four experiments, the proportion of HS11286V declined sharply to less than 10% after 1 h of inoculation and further to under 5% after additional 2 h ( Fig. 2 Kpn Kpn 21 Hypermucoid phenotype transition of Hv-CR- Kpn The impaired intracellular survival of Kpn Fig. 3 Fig. 3 Hypermucoviscosity spontaneously mutated after recovery from the intracellular Kpn a. Kpn b. c. Kpn Kpn Kpn Kpn d. 7 Fig. S4 e. Kpn 46 p HS11286VNM produced significantly less CPS than HS11286V and even less than the parent strain HS11286, as characterised by TEM ( Fig. 3 Fig. S3a Fig. S3b Fig. S3c Fig. S3d Fig. 3 Fig. S4 Kpn 47 Abolished CPS production led to the enhanced within-host persistence of CR- Kpn To further investigate the biological significance of natural loss of CPS, we examined the intracellular survival of HS11286VNM following phagocytosis by macrophages. HS11286VNM exhibited significantly higher intracellular proliferation compared to both HS11286V and HS11286, further indicating that high production of CPS imposes extra burden that impairs Kpn Fig. 4 Fig. 4 Loss of hypermucoid phenotype enhanced within-host persistence of CR- Kpn. p b. Kpn 48 c. p d. 8 Fig. S5 e f p Antibiotics commonly used in clinical practice, such as β-lactam and colistin, exhibit poor permeability to eukaryotic cells. Consequently, enhanced intracellular survival resulted from CPS loss might shield the Kpn 8 Kpn Fig. 4 Fig. 4 Fig. 4 Fig. S5 Kpn Spontaneous transposition of IS Kpn14 K. pneumoniae Kpn To investigate the mechanism underlying the loss of mucoid phenotype in HS11286VNM, we compared the transcription of genes involved in CPS biosynthesis, from galF ugd 49 wbaP Fig. 5 Fig. 5 IS Kpn14 wbaP Kpn a. −ΔΔCt GT ChL Table S9 b. Kpn Kpn 50 Kpn 51 Table S3 c. wbaP d. wbaP e. Kpn14 wbaP wbaP f g wbaP wbaP wbaP p h Kpn14 Kpn Kpn14 Kpn14 52 Then we performed de novo NZ_CP014009.1 Kpn Fig. 5 Table S3 Fig. S6 Fig. S7a 27 wbaP Fig. 5 Fig. S7b Fig. 5 Kpn14 wbaP Fig. 5 Kpn14 wbaP Kpn14 Fig. S7c wbaP wbaP Kpn14 wbaP Fig. 5 No chromosomal IS Kpn14 Kpn14 Kpn Fig. 5 Table S4 wbaP Kpn14 bla KPC-2 Kpn18 903B Ecp1 Fig. S8 Kpn14 1 53 in vitro Kpn insA insA Fig. S9 Kpn14 Loss of CPS enhanced the Kpn Kpn Kpn14 KPC plasmids are reservoirs of IS elements disrupting the CPS loci of clinical virulence plasmid-carrying CR- Kpn We extend the findings on IS-mediated CPS disruption to the 67 KL64 clinical CR- Kpn Table S5 Fig. 6 Kpn14 Kpn26 Fig. S10 orf2 wzi Kpn14 Kpn26 Kpn Kpn14 Kpn26 54 Fig. 6 Screening of IS Kpn14 Kpn26 Kpn a. Kpn14 Kpn Fig. S10 Kpn b. Kpn14 Kpn26 Kpn 34 , 37 Kpn26 Kpn26 Kpn14 Kpn14 c. Kpn bla KPC-2 We next investigated the distribution of these two IS elements on the replicons of 154 Kpn Tables S6 and S7 Fig. 6 Kpn14 Kpn26 Kpn14 Kpn26 Kpn14 Kpn14 Kpn26 Kpn Kpn14 Kpn26 Fig. 6 Table S8 Kpn14 Kpn26 Fig. S11 bla KPC-2 Kpn14 Kpn26 Fig. 6 Table S8 30 , 55 Next, the distribution of IS elements on the 610 bla KPC-2 Kpn 6 Fig. S12a 29 1 5 Kpn14 Kpn26 56 26 bla KPC-2 Kpn14 Kpn26 Fig. S12b In conclusion, the coexistence of virulence plasmids and KPC plasmids in Kpn Kpn Kpn Discussion The increasing convergence of hypervirulence and MDR mediated by plasmid conjugation has made Kpn Kpn Kpn Kpn Kpn 57 , 58 59 Kpn Kpn p rmpA p rmpA2 Kpn Kpn Kpn Kpn Kpn The phagocytes of the human immune system are expected to kill invading bacteria via phagocytosis and digestion, they also can be shelters for bacterial pathogens, as both immune factors and antibiotics are normally not cell permeable. 22 Kpn Kpn Kpn 60 Kpn The CR- Kpn 8 61 Kpn Kpn26 rmpA Kpn 62 insA Kpn14 Kpn While RmpADC and RmpA2, the two well-documented virulence factors on typical virulence plasmid, enhance Kpn Kpn 63 Kpn Kpn p rmpA p rmpA2 This study has several limitations. First, while we collected 195 clinical CR- Kpn Kpn Kpn 54 , 64 Tables S6 and S7 Kpn Contributors YX, GL and JFX conceived and designed the study and acquired funding. YX, ZC, YW and GL collected the clinical bacterial isolates and the corresponding patient information. YX, ZC, YHS, LLW, YW, JZ, and GL performed the experiments. GL and JFX curated the data. ZC, DW, XS and JZ performed the data validation. The original draft was written by YX, ZC, and JFX. GL and JFX reviewed and edited the manuscript. The research was supervised by JFX. All authors have full access to all the data in the present study. All authors read and approved the final version of the manuscript. Data sharing statement The raw sequencing data of K. pneumoniae Declaration of interests The authors declare that they have no conflicts of interest. References 1 Podschun R. Ullmann U. Klebsiella spp. Clin Microbiol Rev 11 4 1998 589 603 9767057 10.1128/cmr.11.4.589 PMC88898 2 Russo T.A. Marr C.M. Hypervirulent Klebsiella pneumoniae Clin Microbiol Rev 32 3 2019 e00001 e00019 31092506 10.1128/CMR.00001-19 PMC6589860 3 Hamdi B. Moussa I. Berraies A. Touil A. Ammar J. Hamzaoui A. Exacerbations of bronchiectasis: etiology and outcome Eur Respir J 48 suppl 60 2016 PA3906 4 Prnjavorac B. Prnjavorac L. Jusufović E. Analysis of microbiological colonization in COPD patients with or without bronchiectasis Eur Respir J 56 suppl 64 2020 1281 5 Flores-Mireles A.L. Walker J.N. Caparon M. Hultgren S.J. Urinary tract infections: epidemiology, mechanisms of infection and treatment options Nat Rev Microbiol 13 5 2015 269 284 25853778 10.1038/nrmicro3432 PMC4457377 6 Yigit H. Queenan A.M. Anderson G.J. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae Antimicrob Agents Chemother 45 4 2001 1151 1161 11257029 10.1128/AAC.45.4.1151-1161.2001 PMC90438 7 Doi Y. van Duin D. Polymyxin resistance in Klebsiella pneumoniae Clin Infect Dis 70 10 2020 2092 2094 31513703 10.1093/cid/ciz627 PMC7201414 8 Sati H. Carrara E. Savoldi A. The WHO bacterial priority pathogens list 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance Lancet Infect Dis S1473-3099 25 2025 118 125 10.1016/S1473-3099(25)00118-5 PMC12367593 40245910 9 Gu D. Dong N. Zheng Z. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae Lancet Infect Dis 18 1 2018 37 46 28864030 10.1016/S1473-3099(17)30489-9 10 Xie Y. Tian L. Li G. Emergence of the third-generation cephalosporin-resistant hypervirulent Klebsiella pneumoniae bla Virulence 9 1 2018 838 844 29683780 10.1080/21505594.2018.1456229 PMC5955457 11 Huang X. Li X. An H. Capsule type defines the capability of Klebsiella pneumoniae PLoS Pathog 18 8 2022 e1010693 10.1371/journal.ppat.1010693 PMC9342791 35914009 12 Cheng H.Y. Chen Y.S. Wu C.Y. Chang H.Y. Lai Y.C. Peng H.L. RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae J Bacteriol 192 12 2010 3144 3158 20382770 10.1128/JB.00031-10 PMC2901686 13 Lai Y.C. Peng H.L. Chang H.Y. RmpA2, an activator of capsule biosynthesis in Klebsiella pneumoniae J Bacteriol 185 3 2003 788 800 12533454 10.1128/JB.185.3.788-800.2003 PMC142793 14 Lim C. Zhang C.Y. Cheam G. Essentiality of the virulence plasmid-encoded factors in disease pathogenesis of the major lineage of hypervirulent Klebsiella pneumoniae eBioMedicine 115 2025 105683 10.1016/j.ebiom.2025.105683 PMC12002934 40184910 15 Walker K.A. Treat L.P. Sepúlveda V.E. Miller V.L. The small protein RmpD drives hypermucoviscosity in Klebsiella pneumoniae mBio 11 5 2020 e01750-20 10.1128/mBio.01750-20 PMC7512549 32963003 16 Xu Y. Zhang J. Wang M. Mobilization of the nonconjugative virulence plasmid from hypervirulent Klebsiella pneumoniae Genome Med 13 1 2021 119 34294113 10.1186/s13073-021-00936-5 PMC8299605 17 Wang S. Ding Q. Zhang Y. Evolution of virulence, fitness, and carbapenem resistance transmission in ST23 hypervirulent Klebsiella pneumoniae wcaJ Microbiol Spectr 10 6 2022 e02400 e02422 10.1128/spectrum.02400-22 PMC9769677 36222687 18 Casadevall A. Fang F.C. The intracellular pathogen concept Mol Microbiol 113 3 2020 541 545 31762116 10.1111/mmi.14421 19 Liu Y. Xie Y.Z. Shi Y.H. Airway acidification impaired host defense against Pseudomonas aeruginosa Emerg Microbes Infect 11 1 2022 2132 2146 35930458 10.1080/22221751.2022.2110524 PMC9487950 20 Wanford J.J. Hames R.G. Carreno D. Interaction of Klebsiella pneumoniae ex-vivo Lancet Microbe 2 12 2021 e695 e703 34901898 10.1016/S2666-5247(21)00195-6 PMC8641047 21 Ernst C.M. Braxton J.R. Rodriguez-Osorio C.A. Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae Nat Med 26 5 2020 705 711 32284589 10.1038/s41591-020-0825-4 PMC9194776 22 Cano V. March C. Insua J.L. Klebsiella pneumoniae Klebsiella Cell Microbiol 17 11 2015 1537 1560 26045209 10.1111/cmi.12466 23 Zhang J. Xu Y. Wang M. Mobilizable plasmids drive the spread of antimicrobial resistance genes and virulence genes in Klebsiella pneumoniae Genome Med 15 1 2023 106 38041146 10.1186/s13073-023-01260-w PMC10691111 24 Yang L. Zhang Y.W. Liu Y. Pseudomonas aeruginosa Microbiol Spectr 2022 e0155022 10.1128/spectrum.01550-22 PMC9603546 36190409 25 Bi D. Jiang X. Sheng Z.K. Mapping the resistance-associated mobilome of a carbapenem-resistant Klebsiella pneumoniae J Antimicrob Chemother 70 10 2015 2770 2774 26169555 10.1093/jac/dkv204 26 Olson R.D. Assaf R. Brettin T. Introducing the bacterial and viral bioinformatics resource center (BV-BRC): a resource combining PATRIC, IRD and ViPR Nucleic Acids Res 51 D1 2023 D678 D689 36350631 10.1093/nar/gkac1003 PMC9825582 27 Chen X. Schulz-Trieglaff O. Shaw R. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications Bioinformatics 32 8 2016 1220 1222 26647377 10.1093/bioinformatics/btv710 28 Robinson J.T. Thorvaldsdóttir H. Winckler W. Integrative genomics viewer Nat Biotechnol 29 1 2011 24 26 21221095 10.1038/nbt.1754 PMC3346182 29 Siguier P. Perochon J. Lestrade L. Mahillon J. Chandler M. ISfinder: the reference centre for bacterial insertion sequences Nucleic Acids Res 34 Database issue 2006 D32 D36 16381877 10.1093/nar/gkj014 PMC1347377 30 Bortolaia V. Kaas R.S. Ruppe E. ResFinder 4.0 for predictions of phenotypes from genotypes J Antimicrob Chemother 75 12 2020 3491 3500 32780112 10.1093/jac/dkaa345 PMC7662176 31 Camacho C. Coulouris G. Avagyan V. BLAST+: architecture and applications BMC Bioinformatics 10 2009 421 20003500 10.1186/1471-2105-10-421 PMC2803857 32 Carattoli A. Zankari E. García-Fernández A. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing Antimicrob Agents Chemother 58 7 2014 3895 3903 24777092 10.1128/AAC.02412-14 PMC4068535 33 Alcock B.P. Huynh W. Chalil R. Card 2023: expanded curation, support for machine learning, and resistome prediction at the comprehensive antibiotic resistance database Nucleic Acids Res 51 D1 2023 D690 D699 36263822 10.1093/nar/gkac920 PMC9825576 34 Seemann T. Tseemann/snippy Available from: https://github.com/tseemann/snippy 2025 35 Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies Bioinformatics 30 9 2014 1312 1313 24451623 10.1093/bioinformatics/btu033 PMC3998144 36 Croucher N.J. Page A.J. Connor T.R. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using gubbins Nucleic Acids Res 43 3 2015 e15 10.1093/nar/gku1196 PMC4330336 25414349 37 Letunic I. Bork P. Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation Nucleic Acids Res 49 W1 2021 W293 W296 33885785 10.1093/nar/gkab301 PMC8265157 38 Wyres K.L. Wick R.R. Gorrie C. Identification of Klebsiella Microb Genom 2 12 2016 e000102 10.1099/mgen.0.000102 PMC5359410 28348840 39 Russo T.A. Olson R. Fang C.T. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae K. pneumoniae J Clin Microbiol 56 9 2018 e00776 e00818 29925642 10.1128/JCM.00776-18 PMC6113484 40 Brisse S. Passet V. Haugaard A.B. Wzi Klebsiella J Clin Microbiol 51 12 2020 4073 4078 10.1128/JCM.01924-13 PMC3838100 24088853 41 Chen Y.T. Chang H.Y. Lai Y.C. Pan C.C. Tsai S.F. Peng H.L. Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae Gene 337 2004 189 198 15276215 10.1016/j.gene.2004.05.008 42 Liu P. Li P. Jiang X. Complete genome sequence of Klebsiella pneumoniae subsp. pneumoniae J Bacteriol 194 7 2012 1841 1842 22408243 10.1128/JB.00043-12 PMC3302456 43 Wang X. Xie Y. Li G. Whole-genome-sequencing characterization of bloodstream infection-causing hypervirulent Klebsiella pneumoniae Virulence 9 1 2018 510 521 29338592 10.1080/21505594.2017.1421894 PMC5955473 44 Walker K.A. Miller V.L. The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae Curr Opin Microbiol 54 2020 95 102 32062153 10.1016/j.mib.2020.01.006 PMC8121214 45 Pizarro-Cerdá J. Cossart P. Bacterial adhesion and entry into host cells Cell 124 4 2006 715 727 16497583 10.1016/j.cell.2006.02.012 46 Wang L.L. Shen X. Xie Y. A gut Eggerthella lenta Sci Transl Med 17 787 2025 eadq4409 10.1126/scitranslmed.adq4409 40009694 47 Russo T.A. Carlino-MacDonald U. Drayer Z.J. Deciphering the relative importance of genetic elements in hypervirulent Klebsiella pneumoniae eBioMedicine 107 2024 105302 10.1016/j.ebiom.2024.105302 PMC11388194 39178743 48 Tsuji B.T. Pogue J.M. Zavascki A.P. International Consensus guidelines for the optimal use of the polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP) Pharmacotherapy 39 1 2019 10 39 30710469 10.1002/phar.2209 PMC7437259 49 Pan Y.J. Lin T.L. Chen C.T. Genetic analysis of capsular polysaccharide synthesis gene clusters in 79 capsular types of Klebsiella spp Sci Rep 5 1 2015 15573 10.1038/srep15573 PMC4616057 26493302 50 Bertels F. Silander O.K. Pachkov M. Rainey P.B. van Nimwegen E. Automated reconstruction of whole-genome phylogenies from short-sequence reads Mol Biol Evol 31 5 2014 1077 1088 24600054 10.1093/molbev/msu088 PMC3995342 51 Yoon S.H. Ha S.M. Lim J. Kwon S. Chun J. A large-scale evaluation of algorithms to calculate average nucleotide identity Antonie Van Leeuwenhoek 110 10 2017 1281 1286 28204908 10.1007/s10482-017-0844-4 52 Chen C. Wu Y. Li J. TBtools-II: a ‘one for all, all for one’ bioinformatics platform for biological big-data mining Mol Plant 16 11 2023 1733 1742 37740491 10.1016/j.molp.2023.09.010 53 Escoubas J.M. Prère M.F. Fayet O. Translational control of transposition activity of the bacterial insertion sequence IS 1 EMBO J 10 3 1991 705 712 1848178 10.1002/j.1460-2075.1991.tb08000.x PMC452705 54 Hu F. Pan Y. Li H. Carbapenem-resistant Klebsiella pneumoniae Nat Microbiol 9 3 2024 814 829 38424289 10.1038/s41564-024-01612-1 PMC10914598 55 Clausen P.T.L.C. Aarestrup F.M. Lund O. Rapid and precise alignment of raw reads against redundant databases with KMA BMC Bioinformatics 19 1 2018 307 30157759 10.1186/s12859-018-2336-6 PMC6116485 56 Fordham S.M.E. Mantzouratou A. Sheridan E. Prevalence of insertion sequence elements in plasmids relating to mgrB Klebsiella pneumoniae Microbiologyopen 11 1 2022 e1262 10.1002/mbo3.1262 PMC8796155 35212479 57 Dhar R. Singh S. Talwar D. Clinical outcomes of bronchiectasis in India: data from the EMBARC/respiratory research network of India registry Eur Respir J 61 1 2023 2200611 10.1183/13993003.00611-2022 PMC9816417 36229049 58 Mao B. Yang J.W. Lu H.W. Xu J.F. Asthma and bronchiectasis exacerbation Eur Respir J 47 6 2016 1680 1686 27076584 10.1183/13993003.01862-2015 59 Liu Y. Lu H.W. Gu S.Y. Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis eBioMedicine 72 2021 103587 10.1016/j.ebiom.2021.103587 PMC8452777 34537448 60 Bakkeren E. Huisman J.S. Fattinger S.A. Salmonella Nature 573 7773 2019 276 280 31485077 10.1038/s41586-019-1521-8 PMC6744281 61 Jiang J. Wang L. Hu Y. Global emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae eBioMedicine 113 2025 105627 10.1016/j.ebiom.2025.105627 PMC11919442 40024096 62 Song S. Yang S. Zheng R. Adaptive evolution of carbapenem-resistant hypervirulent Klebsiella pneumoniae Proc Natl Acad Sci U S A 121 35 2024 e2400446121 10.1073/pnas.2400446121 PMC11363291 39150777 63 Russo T.A. Olson R. MacDonald U. Beanan J. Davidson B.A. Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo in vivo Infect Immun 83 8 2015 3325 3333 26056379 10.1128/IAI.00430-15 PMC4496593 64 Zhu J. Wang G. Xi W. Lactate promotes invasive Klebsiella pneumoniae Nat Commun 16 1 2025 6057 40593854 10.1038/s41467-025-61379-9 PMC12216495 Appendix A Supplementary data  Supplementay Figures and Tables Supplementary Table S9 Supplementary Table S8 A549 [A-549] cells STR report J774A.1 cells STR report Acknowledgements This work was supported by the Noncommunicable Chronic Diseases-National Science and Technology Major Project of China 2024ZD0522400 10.13039/501100001809 National Natural Science Foundation of China 82330070 W2511099 82100004 Key Scientific Innovation Project of Shanghai Municipal Education Commission 202101070007-E00097 Shanghai Sailing Program 20YF1441000 Appendix A Supplementary data related to this article can be found at https://doi.org/10.1016/j.ebiom.2025.105944 ",
  "metadata": {
    "Title of this paper": "Lactate promotes invasive ",
    "Journal it was published in:": "eBioMedicine",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12492035/"
  }
}